Value of ctDNA methylation biomarkers in diagnosis of colorectal tumors.
CpG islands
DNA methylation
advanced adenomas
biomarkers
circulating tumor DNA
colorectal cancer
ctDNA
early-stage diagnosis
epigenetics
liquid biopsy
Journal
Epigenomics
ISSN: 1750-192X
Titre abrégé: Epigenomics
Pays: England
ID NLM: 101519720
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
medline:
10
11
2023
pubmed:
17
10
2023
entrez:
17
10
2023
Statut:
ppublish
Résumé
Tweetable abstract DNA methylation alterations have been identified as promising biological markers for early-stage colorectal cancer detection. Here, the authors highlight some recent advances in DNA methylation and its role in the early diagnosis and overall disease course management of colorectal tumors. New insights into DNA methylation biomarkers for colorectal cancer early diagnosis and management are discussed.
Identifiants
pubmed: 37846515
doi: 10.2217/epi-2023-0227
doi:
Substances chimiques
Biomarkers, Tumor
0
Genetic Markers
0
Types de publication
Editorial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM